Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease.

Trial Profile

Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Oct 2016

At a glance

  • Drugs Febuxostat (Primary)
  • Indications Diabetic nephropathies
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 22 Jan 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
    • 13 May 2013 Planned end date changed from 1 Jul 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top